Screener / SEC EDGAR /CIK 0001809987 /10-K filed Feb 19, 2026, compared with Feb 26, 2025 /Numbers from the XBRL of the 10-Ks
Technology peers:
NYSE Technology · Measuring Instruments

Mirion Technologies, Inc. MIR

At Mirion, we deliver vital protection that unlocks the transformative potential of radiation to move science, industry and medicine forward. 10-K, Item 1

Employees
3,281
Headquarters
Atlanta, GA
Next results
around Feb 9, 2027
Compare with peers Embed

Where each dollar of revenue went, FY2025

Revenue of $925.4M through the costs to a net profit of $28.8M · income statement of the 10-K

6% operating margin
Revenue to Gross profit: $438.6MRevenue to Cost of revenue: $486.8MGross profit to Operating profit: $51.5MGross profit to Operating expenses: $387.1MOperating profit to Net profit: $28.8MOperating profit to Tax & other: $22.7MOperating expenses to R&D: $38.9MOperating expenses to SG&A: $348.2M Revenue: $925.4M REVENUE $925.4M +8% Y/Y Gross profit: $438.6M · 47% margin GROSS PROFIT $438.6M 47% margin · +10% Y/Y Cost of revenue: $486.8M · 53% of revenue COST OF REVENUE $486.8M 53% of revenue Operating profit: $51.5M · 6% margin OPERATING PROFIT $51.5M 6% margin · +108% Y/Y Operating expenses: $387.1M · 42% of revenue OPERATING EXPENSES $387.1M 42% of revenue Net profit: $28.8M · 3% margin NET PROFIT $28.8M 3% margin Tax & other: $22.7M · 2% of revenue TAX & OTHER $22.7M 2% of revenue R&D: $38.9M · 4% of revenue R&D $38.9M 4% of revenue SG&A: $348.2M · 38% of revenue SG&A $348.2M 38% of revenue
Gross profit $438.6M 47% margin · +10% Y/Y
Operating profit $51.5M 6% margin · +108% Y/Y
Net profit $28.8M 3% margin
The full income statement, year by year

MIR among Technology peers

Six ratios from the latest 10-K. Each corner is the share of 230 peers the company is above, not a score.

Compare
Revenue growth: 7.5%, above 30% of 230 peers (their median 13.4%) REVENUE GROWTH 7.5% · above 30% Gross margin: 48.1%, above 31% of 210 peers (their median 61.4%) GROSS MARGIN 48.1% · above 31% Operating margin: 6.0%, above 33% of 222 peers (their median 11.5%) OPERATING MARGIN 6.0% · above 33% Net margin: 2.7%, above 24% of 228 peers (their median 10.4%) NET MARGIN 2.7% · above 24% FCF margin: 15.6%, above 37% of 225 peers (their median 20.0%) FCF MARGIN 15.6% · above 37% Return on capital: 2.1%, above 13% of 160 peers (their median 9.8%) RETURN ON CAPITAL 2.1% · above 13%
MIR Peer median Below the median

What changed

7 new risk paragraphs. 10-K filed Feb 19, 2026 against Feb 26, 2025.

Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.

Accounting checks

11 checks on the latest 10-K. Checks, not verdicts.

How it works

0facts worth reading about all 11 checks found nothing to note

  • Receivables +2.2% ($177.7M to $181.6M) vs revenue +7.5% ($860.8M to $925.4M), -5.3 pts apart
  • Cash from operations $143.3M vs net income $28.8M (FY ending Dec 31, 2025)
  • Inventory +14.6% ($133.2M to $152.6M) vs revenue +7.5% ($860.8M to $925.4M), +7.1 pts apart
8 more checks with nothing to note
  • Same auditor in both 10-Ks: DELOITTE & TOUCHE LLP
  • No statement of substantial doubt about going concern
  • No 8-K item 4.02 in the last 2 years
  • No NT 10-K or NT 10-Q in the last 2 years
  • The same matters as last year: Contracts in Progress; Table of Content s
  • No sentence in the 10-K concludes that controls were not effective because of a material weakness
  • No 8-K item 2.06 in the last 2 years
  • No 8-K item 1.03 in the last 2 years

In their words

7 paragraphs in Risk Factors that were not in the 10-K filed Feb 26, 2025. Quoted as filed.

All 7 new paragraphs
  1. Item 1A · new paragraph · not in the 10-K filed Feb 26, 2025 10-K, ITEM 1A
    We operate in complex markets and regulatory environments and that involves significant risk. You should carefully consider the following risk factors before making an investment decision as they may have an adverse effect on our business, results of operations and financial condition:
  2. Item 1A · new paragraph · not in the 10-K filed Feb 26, 2025 10-K, ITEM 1A
    Following the Paragon acquisition, our growth strategy relies in part on plans to supply our products and services to SMRs and other advanced reactors in the U.S., an emerging market that may grow more slowly than we expect. Our Nuclear and Safety growth strategy relies on market research that estimates that the market for SMRs will…
  3. Item 1A · new paragraph · not in the 10-K filed Feb 26, 2025 10-K, ITEM 1A
    In July 2025 and December 2025 we acquired Certrec and Paragon, respectively. These acquisitions may not meet our expectations. Their success, including anticipated benefits, will depend, in part, on our ability to successfully integrate our respective organizations without materially disrupting existing business and strategic…
  4. Item 1A · new paragraph · not in the 10-K filed Feb 26, 2025 10-K, ITEM 1A
    The use of Artificial Intelligence (AI) and machine learning in our business and operations may result in legal liability, regulatory action, increased compliance obligations, competitive or reputational harm, ethical or other concerns and adversely affect our business, financial condition and results of operations. We leverage…

New risk paragraphs, against peers

Latest 10-K of each, Technology companies closest in revenue

Paragraphs in Risk Factors with nothing like them in the company's 10-K the year before. A count of text, not of risk.

Financial performance

Last 4 fiscal years · 10-K XBRL

All years
MetricFY2022FY2023FY2024FY2025
Revenue$717.8M$800.9M$860.8M$925.4M
Net income−$276.9M−$96.9M−$36.1M$28.8M
Operating cash flow$39.4M$95.2M$99.1M$143.3M
Free cash flow$5.2M$58.1M$50.3M$106.9M

Revenue, FY2019 to FY2025

Ten fiscal years, each from its own 10-K · XBRL · USD

$925.4M ▲ 7.5% in FY2025

FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Every number, year by year

Recent filings

3 filings in the last 30 days · SEC EDGAR

All filings

About the company

Mirion Technologies, Inc., Atlanta, GA · from the 10-K filed Feb 19, 2026

At Mirion, we deliver vital protection that unlocks the transformative potential of radiation to move science, industry and medicine forward. For more than 60 years Mirion and our predecessor companies have provided products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. As a global leader in the field of radiation safety and innovation, we bring together unrivaled expertise with an unmatched range of reliably precise technologies.

Headquarters
Atlanta, GA
Country
United States
Reports in
USD
Listed on
NYSE
Fiscal year ends
December 31
Last results
Oct 27, 2026

Employees, at the top of the page: "As of December 31, 2025, we employed 3,281 full-time and part-time employees" (10-K). Address and exchange: SEC's company file.

Email alerts

Sources

The 10-K filed Feb 19, 2026 (open at SEC), compared with the 10-K filed Feb 26, 2025. Numbers from the XBRL of the 10-Ks; filings from SEC EDGAR.

Work with it: Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/MIR/export.csv") into a cell.

Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.